Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03051685Phase 1Completed
Phase 1, randomised trial of celecoxib oral solution in acute pain (4 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Pharmacokinetic parameters of DFN-15 up to 72 hours. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03051685.